Medicus Pharma Ltd (TSE:MDCX) has released an update.
Medicus Pharma Ltd. has announced Erica Monaco as their new Chief Operating Officer, bringing her extensive experience in dermatology and impressive track record from Biofrontera Inc., where she spearheaded significant revenue growth and an IPO. The company is focusing on innovative treatments for Basal Cell Carcinoma and is exploring US financing and listing opportunities, while also working with Renmark to enhance its market presence.
For further insights into TSE:MDCX stock, check out TipRanks’ Stock Analysis page.
